Epstein Secrets

ed on administrative leave in June after learning he was under investigation by the FBI, the school system's president said Thursday." According to Alabama Live, "Details have not been publicly released about the nature of the investigation, which an FBI spokesman described to AL.com in June as a 'law enforc

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ced on administrative leave in June after learning he was under investigation by the FBI, the school system's president said Thursday." According to Alabama Live, "Details have not been publicly released about the nature of the investigation, which an FBI spokesman described to AL.com in June as a 'law enfor

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

ed on administrative leave in June after learning he was under investigation by the FBI, the school system's president said Thursday." According to Alabama Live, "Details have not been publicly released about the nature of the investigation, which an FBI spokesman described to AL.com in June as a 'law enfor

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug